RO5045337
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for RO5045337, covering 2016-11-02 to 2017-07-07. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies [Phase 1]